BBA
IRWD icon

Baker Bros. Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Baker Bros. Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-201,981
Closed -$1.85M – 137
2016
Q1 		$1.85M Hold
201,981
– – 0.02% 103
2015
Q4 		$1.96M Hold
201,981
– – 0.02% 106
2015
Q3 		$1.76M Hold
201,981
– – 0.02% 107
2015
Q2 		$2.04M Hold
201,981
– – 0.02% 102
2015
Q1 		$2.71M Sell
201,981
-211,334
-51% -$2.77M 0.02% 94
2014
Q4 		$5.3M Hold
413,315
– – 0.05% 71
2014
Q3 		$4.49M Sell
413,315
-119,400
-22% -$1.37M 0.06% 65
2014
Q2 		$6.84M Hold
532,715
– – 0.08% 56
2014
Q1 		$5.5M Sell
532,715
-119,400
-18% -$1.34M 0.07% 68
2013
Q4 		$6.34M Buy
652,115
+101,490
+18% +$911K 0.09% 57
2013
Q3 		$5.46M Sell
550,625
-550,434
-50% -$5.4M 0.08% 55
2013
Q2 		$9.16M Buy
+1,101,059
New +$13.3M 0.18% 38

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Baker Bros. Advisors's IRWD Position: Q2 2016 in Review

Baker Bros. Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2016, closing a stake of 201,981 shares — an estimated $1.85M sold.

Baker Bros. Advisors first reported a position in IRWD in Q2 2013 and held it in 12 quarters. The position peaked at $9.16M in Q2 2013. 145 funds tracked by Wall St. Rank hold IRWD as of Q2 2016.

  • Baker Bros. Advisors reported no remaining Ironwood Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Baker Bros. Advisors sold 201,981 Ironwood Pharmaceuticals shares in Q2 2016, an estimated $1.85M.
  • Baker Bros. Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Baker Bros. Advisors's Ironwood Pharmaceuticals position peaked at $9.16M in Q2 2013.
  • 145 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2016.

Based on Baker Bros. Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.